Recent Updates
Recently added Catalysts
MDT Positive Sentiment Score: 85/100

Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2023 The board of directors of Medtronic plc (NYSE:MDT) on Thursday, March 2, 2023, approved the fiscal year 2023 fourth quarter cash dividend of $0.68...

Key Takeaway: Medtronic plc (NYSE: MDT) announced an increase in its fiscal year 2023 fourth quarter cash dividend to $0.68 per ordinary share, reflecting an 8% rise over the previous year. This dividend declaration aligns with the company's commitment to returning value to shareholders, as evidenced by its consistent annual dividend increase for 45 consecutive years. Shareholders of record as of March 24, 2023, will receive the dividend payable on April 14, 2023.

Market Sentiment Analysis

POSITIVE FACTORS

  • Medtronic increased its cash dividend by 8% compared to the previous year.
  • This marks the 45th consecutive year of annual dividend increases for Medtronic.
  • The company is part of the S&P 500 Dividend Aristocrats index.

Full Press Release Details

DUBLIN , March 2, 2023 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT ) on Thursday, March 2, 2023, approved the fiscal year 2023 fourth quarter cash dividend of $0.68 per ordinary share, representing an 8% increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in May 2022. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 45 consecutive years. The dividend is payable on April 14, 2023, to shareholders of record at the close of business on March 24, 2023.
About Medtronic Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland , is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT ), visit www.Medtronic.com and follow @Medtronic on Twitter and LinkedIn .
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Contacts:
Erika Winkels Ryan Weispfenning
Public Relations Investor Relations
+1-763-526-8478 +1-763-505-4626
SOURCE Medtronic plc

21 %

Frequently Asked Questions

What is the approved dividend for Medtronic in Q4 2023?

Medtronic's board approved a cash dividend of $0.68 per share for Q4 2023.

When is the dividend payable to shareholders?

The dividend is payable on April 14, 2023, to shareholders of record by March 24, 2023.

How long has Medtronic increased its annual dividend?

Medtronic has increased its annual dividend for 45 consecutive years.

What is Medtronic's mission?

Medtronic's mission is to alleviate pain, restore health, and extend life.

How many health conditions does Medtronic's technology address?

Medtronic's technologies treat 70 different health conditions.

Last updated: Mar 2, 2023